The centromeric gene SMN2, identified by researchers in the late 1990s, was determined to be essential in defining the severity of SMA, which is inversely correlated with the quantity of SMN2 genes [6,7]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.